OpGen Company
OpGen is a precision medicine company utilizing molecular diagnostics and bioinformatics to help combat infectious disease.
Founded Date:
2002-01-01
Funding Status:
IPO
Total Funding:
169606744.0
Employee Number:
101-250
Headquarters:
Rockville, Maryland, United States
Last Funding Date:
2023-01-06
Investors Number:
13.0
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$1M to $10M
Industry:
Early Drug Development